logo

Albireo Pharma, Inc. (ALBO)



Trade ALBO now with
  Date
  Headline
8/9/2019 8:02:49 AM Wedbush Is Lowering Albireo Pharma, Inc. (ALBO) FY20 Estimate To -5.48 From -5.41
8/9/2019 8:02:37 AM Wedbush Is Cutting Albireo Pharma, Inc. (ALBO) Q4 20 Estimate To -1.36 From -1.34
8/9/2019 8:02:23 AM Wedbush Is Cutting Albireo Pharma, Inc. (ALBO) Q3 20 Estimate To -1.36 From -1.34
8/9/2019 8:02:06 AM Wedbush Is Cutting Albireo Pharma, Inc. (ALBO) Q2 20 Estimate To -1.37 From -1.36
8/9/2019 8:01:53 AM Wedbush Is Lowering Albireo Pharma, Inc. (ALBO) Q1 20 Estimate To -1.38 From -1.37
8/9/2019 8:01:37 AM Wedbush Is Raising Albireo Pharma, Inc. (ALBO) FY19 Estimate To -5.43 From -5.54
8/9/2019 8:01:25 AM Wedbush Is Raising Albireo Pharma, Inc. (ALBO) Q4 19 Estimate To -1.35 From -1.37
8/9/2019 8:01:14 AM Wedbush Is Increasing Albireo Pharma, Inc. (ALBO) Q3 19 Estimate To -1.35 From -1.36
8/9/2019 8:00:21 AM Wedbush Reiterates Albireo Pharma, Inc. (ALBO) At Outperform With $69 Price Target
4/11/2019 7:34:41 AM Albireo Announces FDA Clearance Of IND To Commence Phase 2 Trial Of Elobixibat For NAFLD/NASH
1/22/2019 8:36:26 AM Albireo Granted Orphan Drug Designation By FDA For Lead Product Candidate A4250 For Biliary Atresia
12/18/2018 8:52:42 AM Albireo Says Granted Orphan Designation By European Commission For A4250 For Treatment Of Biliary Atresia
11/13/2018 7:15:25 AM Albireo Pharma Q3 Net Loss $14.0 Mln Or $1.17/Shr Vs $6.5 Mln Or $0.73/Shr Last Year
10/17/2018 8:36:44 AM Albireo Granted Orphan Drug Designation For Lead Product Candidate A4250 For Alagille Syndrome
10/17/2018 8:34:56 AM Albireo Receives FDA Fast Track Designation For A4250, Ileal Bile Acid Transporter Inhibitor
10/10/2018 8:34:37 AM Albireo Pharma Names Simon Harford As CFO And Treasurer
8/7/2018 8:27:30 PM Wedbush Reiterates Albireo Pharma, Inc. (ALBO) At Outperform With $69 Price Target
8/7/2018 7:33:39 AM Albireo Pharma Q2 Net Loss $14.6 Mln Or $1.22/Shr; Revenues $730 Thousand
7/25/2018 8:38:51 AM Albireo Appoints Patrick Horn As Chief Medical Officer